Publications by authors named "Gefion Girbig"
Background And Objectives: Due to increasing skin cancer incidence, Germany implemented a statutory nationwide routine skin cancer screening (rSCS) in 2008. The present study aims (1) to analyze which patient factors are associated with the participation in rSCS in Germany and (2) to investigate reasons for nonparticipation.
Patients And Methods: Participants and nonparticipants of rSCS (≥ 35 years) were recruited in routine care in nine dermatological outpatient clinics.
Article Synopsis
- * A study analyzed 94 patients who switched from ADAO to ABP 501, and found that 33.3% experienced adverse events (AEs) or loss of response (LoR) within 12 to 14 weeks after the switch.
- * The findings suggest that switching from ADAO to ABP 501 significantly impacts treatment effectiveness, indicating that such switches should be carefully considered, especially for patients maintaining remission.
Background: In Germany, skin diseases are mainly treated in the 115 dermatological hospitals.
Methods: Health care and health economic analysis of dermatological inpatient care and prediction of future care needs based on primary and secondary data.
Results: Outpatient and inpatient care for dermatologic treatment indications is predominantly provided by dermatology specialists.
Background: The objective of the study was to characterize the performance of German dermatology hospitals.
Methods: A structured survey questionnaire was sent out to all dermatology hospitals in October 2019 as part of a cross-sectional analysis based on health care research.
Results: Of the 115 hospitals, 95 (82.
Background: Inpatient care in Germany has been subject to change since the introduction of the DRG-based payment system. There have been no publications on important differentiating factors such as the spectrum of care and the staffing situation in dermatology.
Methods: Health care analysis of 115 dermatology hospitals in October 2019 using a structured survey questionnaire.
Background: Scabies is one of the most common and, in terms of burden of disease, one of the most significant skin diseases worldwide. In Germany, an increase in cases is currently being discussed, for which reliable data have been lacking until now.
Objectives: The goal is to clarify the prevalence and treatment of scabies in Germany.
Background: In 2008, statutory skin cancer screening (gesetzliches Hautkrebsscreening, gHKS), conducted by dermatologists or general practitioners, was introduced in Germany. The aim was earlier detection of cancer and therefore improved health care delivery. To assess the success of the gHKS and to increase utilization, the opinion of the population on access to the gHKS is of great relevance.
View Article and Find Full Text PDF